Effects of antiretroviral therapy on immune function and arterial inflammation in treatment-naive patients with human immunodeficiency virus infection

JAMA Cardiology

Volumn 1, Issue 4, 2016, Pages 474-480

  Zanni, Markella V ^a   Toribio, Mabel ^a   Robbins, Gregory K ^a   Burdo, Tricia H ^b   Lu, Michael T ^c   Ishai, Amorina E ^c   Feldpausch, Meghan N ^a   Martin, Amanda ^a   Melbourne, Kathy ^d   Triant, Virginia A ^a   Suchindran, Sujit ^a   Lee, Hang ^a   Hoffmann, Udo ^c   Williams, Kenneth C ^b   Tawakol, Ahmed ^c   Grinspoon, Steven K ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BOSTON COLLEGE   (United States)

^c Division of Cardiology   (United States)

^d GILEAD SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR AGENT; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; EMTRICITABINE;

ADULT; AGED; ARTICLE; CARDIOLOGIST; CLINICAL PRACTICE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; OUTPATIENT; PATIENT ATTITUDE; PATIENT EDUCATION; PHYSICIAN ATTITUDE; QUESTIONNAIRE; RATING SCALE; ARTERITIS; CD4 LYMPHOCYTE COUNT; DIAGNOSTIC IMAGING; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLAMMATION; MIDDLE AGED; VIRUS LOAD; YOUNG ADULT;

ADULT; ANTI-HIV AGENTS; ARTERITIS; CD4 LYMPHOCYTE COUNT; EMTRICITABINE; HIV INFECTIONS; HUMANS; INFLAMMATION; MIDDLE AGED; VIRAL LOAD; YOUNG ADULT;

EID: 85017382317     PISSN: 23806583     EISSN: 23806591     Source Type: Journal    
DOI: 10.1001/jamacardio.2016.0846     Document Type: Article

References (17)

1. Triant VA, Lee H, Hadigan C, Grinspoon SK. Increased acutemyocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metab. 2007;92(7):2506-2512.
2. FreibergMS, Chang CC, Kuller LH, et al. HIV infection and the risk of acutemyocardial infarction. JAMA Intern Med. 2013;173(8):614-622.
3. Hsue PY, Deeks SG, Hunt PW. Immunologic basis of cardiovascular disease in HIV-infected adults. J Infect Dis. 2012;205(suppl 3):S375-S382.
4. Zanni MV, Schouten J, Grinspoon SK, Reiss P. Risk of coronary heart disease in patients with HIV infection. Nat Rev Cardiol. 2014;11(12):728-741.
5. Friis-Moller N, Reiss P, Sabin CA, et al; DAD Study Group. Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med. 2007;356(17): 1723-1735.
6. Phillips AN, Carr A, Neuhaus J, et al. Interruption of antiretroviral therapy and risk of cardiovascular disease in persons with HIV-1 infection: Exploratory analyses from the SMART trial. Antivir Ther. 2008; 13(2):177-187.
7. Figueroa AL, Abdelbaky A, Truong QA, et al. Measurement of arterial activity on routine FDG PET/CT images improves prediction of risk of future CV events. JACC Cardiovasc Imaging. 2013;6(12): 1250-1259.
8. Subramanian S, Tawakol A, Burdo TH, et al. Arterial inflammation in patients with HIV. JAMA. 2012;308(4):379-386.
9. clinicaltrials.gov. Effects of Newly-Initiated QUAD Therapy on Aortic/Coronary Inflammation in ART-Naive Infected Patients. NCT01766726. https: //clinicaltrials.gov/ct2/show/NCT01766726. Accessed April 15, 2016.
10. Lo J, LuMT, Ihenachor EJ, et al. Effects of statin therapy on coronary artery plaque volume and high-risk plaque morphology in HIV-infected patients with subclinical atherosclerosis: A randomised, double-blind, placebo-controlled trial. Lancet HIV. 2015;2(2):e52-e63.
11. TawakolA, Fayad ZA, Mogg R, et al. Intensification of statin therapy results in a rapid reduction in atherosclerotic inflammation: Results of a multi-center FDG-PET/CT feasibility study. J Am Coll Cardiol. 2013;62(10):909-917.
12. SabatineMS, Morrow DA, O'Donoghue M, et al; PEACE Investigators. Prognostic utility of lipoprotein-associated phospholipase A2 for cardiovascular outcomes in patients with stable coronary artery disease. Arterioscler Thromb Vasc Biol. 2007;27(11):2463-2469.
13. Funderburg NT, Andrade A, Chan ES, et al. Dynamics of immune reconstitution and activation markers in HIV+ treatment-naive patients treated with raltegravir, tenofovir disoproxil fumarate and emtricitabine. PLoS One. 2013;8(12):e83514.
14. McCausland MR, Juchnowski SM, Zidar DA, et al. Altered monocyte phenotype in HIV-1 infection tends to normalize with integrase-inhibitor-based antiretroviral therapy. PLoS One. 2015;10(10):e0139474.
15. Thomas G, Tacke R, Hedrick CC, Hanna RN. Nonclassical patrolling monocyte function in the vasculature. Arterioscler Thromb Vasc Biol. 2015;35 (6):1306-1316.
16. Lepist EI, Zhang X, Hao J, et al. Contribution of the organic anion transporter OAT2 to the renal active tubular secretion of creatinine and mechanism for serum creatinine elevations caused by cobicistat. Kidney Int. 2014;86(2):350-357.
17. Lundgren JD, Babiker AG, Gordin F, et al; INSIGHT START Study Group. Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med. 2015;373(9):795-807.